Antiplasmodial, Antioxidant, and Cytotoxic Activity of <i>Bridelia micrantha</i> a Cameroonian Medicinal Plant Used for the Treatment of Malaria

Kevin, Tako Djimefo Alex; Cedric, Yamssi; Nadia, Noumedem Anangmo Christelle; Sidiki, Ngouyamsa Nsapkain Aboubakar; Azizi, Mounvera Abdel; Guy-Armand, Gamago Nkadeu; Sandra, Tientcheu Noutong Jemimah; Christian, Mbohou Nchetnkou; Géraldine, Essangui Same Estelle; Roméo, Tankoua-Tchounda; Payne, Vincent Khan; Gustave, Lehmann Léopold

doi:https://doi.org/10.1155/2023/1219432

BioMed Research International

On this page

Abstract Introduction Methods Results Discussion Conclusion Data Availability Conflicts of Interest Authors’ Contributions Acknowledgments References Copyright Related Articles

Research Article | Open Access

Volume 2023 | Article ID 1219432 | https://doi.org/10.1155/2023/1219432

Antiplasmodial, Antioxidant, and Cytotoxic Activity of Bridelia micrantha a Cameroonian Medicinal Plant Used for the Treatment of Malaria

Tako Djimefo Alex Kevin,¹Yamssi Cedric,²Noumedem Anangmo Christelle Nadia,³Ngouyamsa Nsapkain Aboubakar Sidiki,⁴Mounvera Abdel Azizi,⁴Gamago Nkadeu Guy-Armand,⁴Tientcheu Noutong Jemimah Sandra,⁴Mbohou Nchetnkou Christian,¹Essangui Same Estelle Géraldine,⁵Tankoua-Tchounda Roméo,¹Vincent Khan Payne,⁵and Lehmann Léopold Gustave¹

Academic Editor: Ali Imran

Received19 Sept 2022

Revised21 Nov 2022

Accepted23 Mar 2023

Published11 Apr 2023

Abstract

Introduction. Resistance to common antimalarial drugs and persistence of the endemicity of malaria constitute a major public health problem in Cameroon. The aim of this study was to evaluate the in vitro antiplasmodial, antioxidant, and cytotoxic activities of aqueous and ethanol extracts of Bridelia micrantha used by Cameroonian traditional healers for the treatment of malaria. Methods. Aqueous and ethanolic stem bark extracts were prepared according to standard procedures. The SYBR Green method was used for antiplasmodial activity on strains of Plasmodium falciparum sensitive to chloroquine (3D7) and resistant (Dd2). In vitro antioxidant activities of B. micrantha were determined using the scavenging activity of 2,2-diphenyl-1-picrylhydrazyl, nitric oxide, ferric reducing power, and hydrogen peroxide as well as their cytotoxicity on RAW 264.7 macrophage cells and red blood cells (RBC). Results. The aqueous and ethanol extracts of Bridelia micrantha showed antiplasmodial activity on the 3D7 strain with of μg/ml and μg/ml, respectively, as well as μg/ml and μg/ml for the Dd2 strain, respectively. The aqueous and ethanol extracts showed free radical scavenging properties. The aqueous and ethanol extract was approximately 0.0001737 μg/ml, 42.92 μg/ml, 1197 μg/ml, 63.78 μg/ml and 4.617 μg/ml, 429.9 μg/ml, 511 μg/ml, and 69.32 μg/ml for DPPH, NO, H2O2, and FRAP, respectively, which were compared to ascorbic acid ( μg/ml, 2901 μg/ml, 3237 μg/ml, and 18.57 μg/ml). The aqueous and ethanol extracts of B. micrantha were found to be nontoxic with values of μg/ml and μg/ml, respectively. Haemolysis test showed that the two extracts were not toxic. Conclusion. These results suggest that B. micrantha can serve as an antimalarial agent. However, further studies are needed to validate the use of B. micrantha as an antimalarial.

1. Introduction

Malaria is caused by a protozoan of the genus Plasmodium that is transmitted to humans by the bite of an infected female anopheles mosquito [1]. It is characterised by fever and haemolytic erythrocytopathy due to its presence and development in the liver and red blood cells (RBCs). Malaria is one of the most widespread parasitic diseases globally representing one of the deadliest pandemics for countries in sub-Saharan Africa [2]. It is endemic in the tropical and subtropical areas of Africa, Latin America, and South and South-east Asia, constituting a significant global health burden [3] with about 229 million cases reported in 2021 and over 409,000 deaths. Africa remains the most infected continent, with around 213 million cases recorded [3].

Cameroon is among the 18 countries with 90% of deaths caused by malaria, and 71% of its population is living in areas of high transmission [4]. Children under 5 years and pregnant women are the most infected [5, 6]. Malaria is a major threat having a devastating impact on the public health and well-being of Cameroonians [7–9]. According to the Ministry of Public Health, malaria is the leading cause of consultation (26%), hospitalization (46%), deaths (22%), and annual household health budgets (40%) [8].

In the absence of an effective vaccine against malaria, chemotherapy, chemoprophylaxis, and vector control remain the principal means of managing malaria. The adoption of artemisinin-based combination therapies (ACTs) as first-line drugs for more than 15 years has led to a reduction in mortality in tropical and subtropical regions. However, this achievement is seriously threatened by decreased clinical efficacy of artemisinins [10], as well as their high cost. Humans have long exploited nature as a source of food and medicine. Plants are thus the oldest and most important healing resource available to man [11]. The WHO estimates that over 20,000 plants are used for the treatment of malaria around the world [12]. Traditional healers in the West Region of Cameroon use Bridelia micrantha to treat malaria, headaches, gastric ulcers, coughs, rheumatism, dysentery, ethnoveterinary medicine, sexually transmitted infections, stomach aches, tapeworms, and diarrhoea [13].

However, the antiplasmodial effect of this plant has not been scientifically evaluated on the different stages of development of P. falciparum.

According to Noumedem et al. [14], there is a direct relationship between malaria and oxidative stress. A plasmodial infection leads to the overproduction of reactive oxygen species. These free radicals are not only toxic to the parasite; they are equally toxic to the host organism. Hence, an antiplasmodial remedy with good antioxidant properties will be an advantage. This study therefore reports the antiplasmodial and antioxidant activities of B. micrantha used by traditional healers in the Western Region of Cameroon to treat malaria.

2. Material and Methods

2.1. Collection and Identification

Bridelia micrantha’s stem bark was collected in 2021 in Foumban, West Region of Cameroon. The leaves, seeds, and flowers were sent to the National Herbarium of Cameroon for identification with reference number 64129/HNC attributed to the voucher specimen.

2.2. Preparation of Plant Extracts

Powder B. micrantha (100 grams) using an electrical balance (SF-400) was weighed into a 2-litre container, with an addition of 95% ethanol (one litre) followed by agitation for five minutes and maceration for 72 hours. Whatman paper no. 3 was used to filter the homogenate with the resulting filtrate evaporated at 45°C in an oven [15]. The aqueous extract was prepared by infusion in distilled water at 100°C for three hours, followed by filtration to obtain the filtrate.

2.3. In Vitro Antiplasmodial Activity

2.3.1. Plasmodium Strain Culture

The Trager [16] technique was used with slight modification. Fresh human group O⁺ red blood cells were used to culture the chloroquine-sensitive Plasmodium falciparum strain 3D7 and the multiresistant Plasmodium falciparum strain Dd2 at 4% hematocrit in complete RPMI medium ((Gibco, UK) supplemented with 25 mM HEPES (Gibco, UK), 0.50% Albumax I (Gibco, USA), 1Xhypoxanthine (Gibco, USA), and 20 μg/ml gentamicin (Gibco, China)) and incubated at 37°C in a humidified incubator consisting of N (92%), CO₂ (5%), and O₂ (3%).

2.3.2. Synchronization of the Culture

The parasite cultures that included a majority of the ring stage (>80%) were synchronized at the ring stage before testing antiplasmodial activity. This was done by treating them with 5% () sorbitol for 10 minutes [17].

2.3.3. In Vitro Test for P. falciparum Growth Inhibition Based on Present Full Meaning of the Acronym (SYBR) Green Fluorescence

The in vitro antiplasmodial activity was evaluated according to the method described by Smilkstein et al. [18]. Briefly, 10 μl of the various concentrations of extracts, artemisinin, and chloroquine were put in contact into a 96-well microplate titer with 90 μl of the parasite suspension at the ring stage of 2% parasitemia and 1% hematocrit. The plates were then incubated for 72 hours at 37°C in a CO₂ incubator. The final plant extract concentration ranged from 0.01258 to 200 μg/ml. This experiment was done in triplicates. One hundred microlitres (100 μl) of SYBR Green was added into each well followed by an hour of incubation in the darkness. The result of the antiplasmodial activity was read using an ELISA fluorescence microplate reader (Tecan Infinite M200) at an excitation and emission wavelength of 485 and 538 nm, respectively. The resistance index (RI) was calculated using the formula:

2.4. In Vitro Antioxidant Activity of B. micrantha

2.4.1. DPPH Antiradical Activity

The antifree radical activity will be measured using DPPH by the method of [19]. In the spectrophotometer cuvettes, 0.5 ml of plant or vitamin C extracts (at different final concentrations: 1, 3, 10, 30, 100, and 300 μg/ml) will be mixed with 0.5 ml of methanol and 0.5 ml of DPPH (0.063 mg/ml). The blank will consist of 1 ml of methanol and 0.5 ml of DPPH. The absorbance will be read at 517 nm before (DOi) and 20 minutes (DOf) after the introduction of the DPPH solution into the reaction medium, respectively. Vitamin C will serve as a positive control and the test will be performed in 3 replicates.

2.4.2. Ferric Reducing Power

The procedure described by Bokhari et al. [20] was followed with slight modification. Briefly, 200 μl of plant extracts/vitamin C were added to test tubes together with 0.5 ml of phosphate-buffered solution (200 mM, pH 6.6) and 0.5 ml of potassium ferricyanide solution. The final concentrations of the plant extracts and vitamin C were 1, 3, 10, 30, 100, and 300 g/ml (30 mM). The absorbance was measured at 700 nm, and the mixture will be incubated for 10 minutes of incubation at 37°C. The test was carried out in triplicate.

2.4.3. Nitric Oxide (NO) Inhibition Test (IT)

When oxygen and NO are combined in vitro at physiological pH, they create nitrite ions which may be detected by the Griess reaction [21]. Ten milligrams (10 mg) of extract and vitamin C (at a concentration of 1, 3, 10, 30, 100, or 300 g/ml) were dissolved in 3.53 ml of phosphate-buffered saline (, 10 mH, ) to obtain a stock solution. Briefly, 1520 μl of sodium nitroprusside (10 mM) was introduced into test tubes containing 180 μl of Aframomum pruinosum or vitamin C extract. The mixture was incubated at 25°C for 2 h 30 min. At the end of the incubation, 500 μl of the previous mixture was taken and introduced into spectrophotometer cuvettes, and then, an equivalent volume of 1% sulfanilamide was added. The mixture was homogenized and incubated for 5 min at room temperature in the dark. 500 μl of naphthyl ethylenediamine (NED, 0.1%) was added to the mixture, followed by another 5 minutes of incubation in the darkness. The absorbance was read at 530 nm to measure the production of the chromophore. The scavenging activity was calculated as follows:

2.4.4. Hydrogen Peroxide Scavenging Activity

The procedure described by Ruch et al. [22] was used to assess if plant extracts have the capacity to break down hydrogen peroxide. Briefly, 0.4 ml of extract at various concentrations (1, 3, 10, 30, 100, or 300 g/ml) was promptly added to 0.6 ml of a hydrogen peroxide solution (40 mM) made in phosphate buffer (pH 7.4, 50 mM). The absorbance of the mixture was measured at 230 nm after ten minutes. Ascorbic acid was considered as a positive control.

2.5. Cytotoxic Test

2.5.1. Haemolysis Test

The haemolysis test against healthy erythrocytes was carried out according to the method described by Sinha et al. [23]. Five hundred microlitres (500 μl) of a suspension of healthy erythrocytes from fresh O⁺ blood was prepared at 4% hematocrit in incomplete RPMI1640, in the presence of 500 μl plant extracts at different concentrations in the Eppendorf tubes. Under the same conditions, Triton X-100 at 0.5% (for 100% haemolysis) and the erythrocyte suspension in an incomplete culture medium at 4% hematocrit were used as positive control and negative control, respectively. The final concentrations in the test plates varied from 1000 to 62.5 μg/ml (0.5% DMSO) for the extracts and 0.5% for the Triton X-100 in a final volume of 1000 μl. The plates were incubated at 37°C for 3 hours. After incubation followed by centrifugation at 2500 rpm/3 min, the absorbance of the supernatant corresponding to the release of hemoglobin was measured at 540 nm using the Infinite M200 microplate reader (Tecan). The haemolysis rate of the various extracts was estimated using the formula: where is the absorbance of sample, is the absorbance of negative control, and is the absorbance of positive control.

2.5.2. Cytotoxicity Test on RAW 264.7 Cells

The resazurin-based assay [24] was used to test the extract’s ability to kill RAW 264.7 cells. Macrophages were seeded at a density of 10⁴ cells per 100 μl of complete media. After a 24-hour incubation at 37°C with 5% CO₂, test plates were filled with 10 μl of each serially diluted test sample solution (extract) and then incubated for another 48 hours. Ten microlitres of 0.15 mg/ml of resazurin was added to each well and incubated for 4 hours. Cell proliferation was assessed by measuring the absorbance at 540 nm using the plate reader (Tecan Infinite M200). The selectivity index (SI) was calculated according to the following formula:

For this purpose, the regression lines were drawn using the values read from the different inhibition percentages and the decimal logarithm of the extract concentrations . The equations of the regression lines of the form were used. Assuming each time that , we obtain and , where .

2.6. Statistical Analysis

The fluorescence values obtained were used to calculate the percentage inhibition using the Microsoft Excel software. Next, the replicate number averages of the 50% inhibitory concentration () were determined using concentration-response curves obtained by plotting the logarithm of the concentration versus the percentage inhibition using the GraphPad Prism 8 software. was significant.

3. Results

3.1. In Vitro Antiplasmodial Activity of Bridelia micrantha

Table 1 shows the of the aqueous and ethanol extracts of B. micrantha on chloroquine-resistant (Dd2) and chloroquine-sensitive (3D7) strains. It appears from this table that the ethanol extract was more active than the aqueous extract on the Dd2 and 3D7 strains, with values of g/ml and g/ml, respectively. The aqueous and ethanol extracts had resistance indexes (RI) of 1.18 and 1.9, respectively.

3.2. Antioxidant Activity of B. micrantha

3.2.1. DPPH Scavenging Activity

Figure 1 shows the scavenging activity of B. micrantha. The aqueous and ethanol extract have inhibited the production of a DPPH radical. Ascorbic acid showed an of , whereas the aqueous and ethanol extracts had values of 0.0001737 μg/ml and 4.617 μg/ml, respectively.

3.2.2. Nitric Oxide Free Radical Inhibition

The results obtained from the NO production inhibition test are represented in Figure 2. This figure shows that the aqueous and ethanol extracts decrease the production of NO with an increase in the concentration of the extracts. The values of the aqueous extract, ethanolic extract, and ascorbic acid were 42.92, 429.9, and 2901 μg/ml, respectively.

3.2.3. Free Radical Scavenging of Hydrogen Peroxide

Figure 3 shows the results obtained for the hydrogen peroxide test of the extracts. The results obtained showed that the standard and extract absorbance increased with respect to concentrations. It emerges from this figure that the aqueous and ethanol extracts inhibited the production of hydrogen peroxide more than ascorbic acid. The of ascorbic acid was 3237 μg/ml which was higher than that of the aqueous and ethanol extracts, with of 1197 and 511 μg/ml, respectively.

3.2.4. FRAP Scavenging Activity

The reducing power activity of the extracts is presented in Figure 4. This figure shows that the aqueous and ethanol extracts of B. micrantha demonstrated significant reducing activity. The values of the aqueous and ethanol extracts were 63.78 and 69.32 μg/ml, respectively, and were three times greater than that of ascorbic acid which was found to be 18.57 μg/ml. The results obtained show that the standard and extract absorbances increased as a function of concentrations. Moreover, absorbances of the standard remain higher than that of the extracts.

3.3. Cytotoxic Activity of B. micrantha

3.3.1. Cytotoxicity on RAW 264.7 Cells

Table 2 presents the results of the cytotoxicity test on RAW 264.7 macrophage cells. It emerges from this table that the aqueous and ethanol extracts had no significant activity on the RAW 264.7 macrophage cells with of μg/ml and μg/ml for aqueous and ethanol extracts, respectively. The reference drug used was podophyllotoxin with a high of μg/ml. The selectivity index of the ethanol extract was low (15.9 and 8.51, respectively, of the Plasmodium strains 3D7 and Dd2) compared to that of the aqueous extract (30.1 and 25.23, respectively, of the Plasmodium strains 3D7 and Dd2).

3.3.2. Haemolysis Test

The haemolytic activity of plant extracts is expressed as a percentage of haemolysis. The two samples exhibited a very weak haemolytic effect against human erythrocytes. However, these extracts showed a dose-dependent increase in haemolytic activity (Figure 5). The concentrations of 1000 μg/ml and 62.5 μg/ml had an inhibition percentage of 18.86% and 1.52%, respectively.

4. Discussion

The results of our investigation showed that the values of the aqueous and ethanolic extracts were μg/ml and μg/ml and μg/ml and μg/ml, respectively, for susceptible Pf3D7 and resistant PfDd2 strains. According to the classification of Kumari et al. [25], when the is higher than 5 μg/ml, the extract is considered very active; when it is between 5 and 50 μg/ml, it is active; when it is between 50 and 100 μg/ml, its activity is moderate; and when it is higher than 100 μg/ml, it is inactive. We can conclude that our aqueous and ethanolic extracts are active on susceptible Pf3D7 and resistant PfDd2 strains. In Nigeria, a similar study was conducted, and the for B. micrantha was g/ml [26]. The obtained by Ramadhani et al. [27] was 8 g/ml for B. micrantha decoction. The difference in observed may be due to the fact that different strains of Plasmodium were used to conduct the experiment. It appears from this study that the ethanolic extract was more active than the aqueous extract. Our results are similar to those obtained by Tomani et al. [28] with Eriosema montanum Baker f. roots on Plasmodium 3D7 strain which had obtained an of μg/ml of ethanolic extract and different from that obtained by Esseh et al. [29] which had an of μg/ml of aqueous extract. This difference can be explained by the type of extract, and the strain of Plasmodium used in this study, as well as the geographical location of the plant, may have had an impact on the observed difference. The resistance index (RI) indicates the inhibitory potential of a drug against sensitive and resistant strains of P. falciparum. The resistance index was in the range of 1.18 to 1.9. Extract with is considered promising against sensitive and resistant strains. This shows that the extract of B. micrantha had good resistance indices and was classified as interesting and promising.

Bridelia micrantha extracts demonstrated strong DPPH free radical scavenging efficacy implying that they possess robust antioxidant properties. The values of the extracts were 0.00017 μg/ml and 4.617 μg/ml for the aqueous and ethanol. A similar study carried out on Euphorbia neriifolia of the same family had an of inhibition [30]. This could be justified by the fact that all plants belonging to the same family do not necessarily have the same mode of action. Bridelia micrantha extract has the ability to donate protons that can serve as an inhibitor or scavenger of free radicals, acting as a primary [30].

These plant extracts increased the amount of nitrite produced from the breakdown of sodium nitroprusside in vitro, suggesting that direct scavenging of the NO radical may not be related to the suppression of its release. The plant extract did not significantly improve the dose-dependent scavenging of nitric oxide. The values for the extracts were 42.92 μg/ml for the aqueous and 429.9 μg/ml for the ethanol extract, while the value of ascorbic acid was 2901 μg/ml. This result suggests that B. micrantha extracts would not intercept the NO formation reaction from nitroprusside but would rather act in favor of this reaction. On the other hand, these extracts could be beneficial in the management of arterial hypertension, one of the major characteristics of which is the decrease in the bioavailability of NO. Nitric oxide and superoxide anions have the potential to injure a variety of tissues. Peroxynitrite (ONOO^-), which is formed when NO and O^2- react, worsens the toxicity profile and damages it because it causes toxic interactions with biomolecules [31, 32]. The cascade of reactions triggered by excessive NO formation can be stopped by scavenging the reactive peroxynitrite, which will help stop the negative effects that these radicals have in the human body.

The H₂O₂ scavenging activity of the aqueous and ethanolic extracts was slightly higher than the positive control. The values of the extract were 1197 μg/ml and 511 μg/ml for the aqueous and ethanol, while the value of ascorbic acid was 3237 μg/ml. Hydrogen peroxide can produce hydroxyl ions in the presence of iron ions, which can be harmful to cells [33]. Therefore, in order to provide antioxidant defense, H₂O₂ must be removed from cells. The reducing power of B. micrantha extracts increases as the concentration increases. This is so because reducers break the chain of the free radicals donating a hydrogen atom. Their presence is closely related to the reducing activities of extracts [34]. Since a considerable reducing activity was noticed, it means our plant extracts contain phytochemical constituents capable of reacting with ferric-tripyridyl triazine (Fe³⁺-TPTZ) complex to produce Fe²⁺-TPTZ as the end product.

The values of the extracts in this study were μg/ml and μg/ml for the aqueous and ethanol extracts, respectively, on RAW 264.7 macrophage cells. According to the cytotoxicity classification of Malebo et al., [35] a μg/ml is high cytotoxicity, μg/ml is moderate cytotoxicity, μg/ml is average cytotoxicity, and μg/ml is noncytotoxic. Hence, the extracts from B. micrantha can be classified as nontoxic. The aqueous extract had a SI of 30.01 and 25.23 for Pf3D7 and PfDd2, respectively, and was higher than that of the ethanol extract which was 15.9 and 8.51 for Pf3D7 and PfDd2, respectively. A similar study was conducted by Bapela et al. [36] on B. mollis Hutch where they had a of 51.4 μg/ml with a SI of 17. The difference observed here may be due to the cell strain used for the cytotoxicity test.

Many researchers have used erythrocytes as a model system to explore the interaction of drugs with membranes [37]. The concentration and potency of the extract are linked to haemolysis. In addition, the chemical composition of each extract affects its haemolytic action. The aqueous and ethanol extracts of B. micrantha had no effect and does not affect the erythrocyte membrane at low concentrations, but attention should be given to high doses like 1000 μg/ml.

5. Conclusion

The aqueous and ethanol extracts of B. micrantha were found to be active against Plasmodium falciparum-sensitive 3D7 and -resistant Dd2 strains but nontoxic on RBCs and macrophage cells (RAW 264.7). The results also showed that the aqueous and ethanol extracts of B. micrantha have promising antioxidant activity, suggesting that it may be useful in the prevention of many oxidative stress-related diseases. However, studies must be carried out to scientifically confirm the use of B. micrantha as an antiplasmodial remedy and to assess its safety.

Data Availability

All data generated and analyzed are included in this research article.

Conflicts of Interest

The authors declare that there is no conflict of interest.

Authors’ Contributions

TDAK, YC, and NACN conceived the idea and designed the experiments. TDAK, NNAS, MAA, GNG, TNJS, MNC, EE, VKP, TTR, and LLG performed the experiments. TDAK analyzed and interpreted the data. TDAK also wrote the manuscript. All Authors have read and approved the final manuscript.

Acknowledgments

The authors wish to thank the American Type Culture Collection (ATCC) who kindly donated the Plasmodium strain used in the study. We will also like to thank Prof. Walter Luyten, KU Leuven, Belgium, who provided the necessary equipment and chemicals to carry out this study.

References

J. B. G. Yaméogo, G. Annabelle, C. Luc et al., “Self-assembled biotransesterified cyclodextrins as Artemisinin nanocarriers – I: Formulation, lyoavailability and in vitro antimalarial activity assessment,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 80, no. 3, pp. 508–517, 2012.
View at: Publisher Site | Google Scholar
S. Chouto and A. Wakponou, “Disparités spatio-temporelles et prévalence du paludisme à partir des données formelles : cas de Kousséri (Extrême-Nord Cameroun),” Journal of Ecology and the Natural Environment, p. 21, 2017.
View at: Google Scholar
OMS, Rapport sur le paludisme dans le monde 2020, Résume, 2021.
D. Zofou, M. Tene, M. N. Ngemenya, P. Tane, and V. P. Titanji, “_In Vitro_ Antiplasmodial Activity and Cytotoxicity of Extracts of Selected Medicinal Plants Used by Traditional Healers of Western Cameroon,” Malaria Research and Treatment, vol. 2011, Article ID 561342, 6 pages, 2011.
View at: Publisher Site | Google Scholar
C. N. Mbohou, L. P. Foko, H. N. Nyabeyeu et al., “Malaria screening at the workplace in Cameroon,” PLoS One, vol. 14, no. 12, p. e0225219, 2019.
View at: Publisher Site | Google Scholar
N. N. Sidiki, V. K. Payne, Y. Cedric, and N. A. Nadia, “Effect of impregnated mosquito bed nets on the prevalence of malaria among pregnant women in Foumban subdivision, West Region of Cameroon,” Journal of Parasitology Research, vol. 2020, Article ID 7438317, 10 pages, 2020.
View at: Publisher Site | Google Scholar
P. N. Akono, A. M. Mbida, C. Tonga, A. Y. Kayoum, L. E. Youmbi, and L. G. Lehman, “Données préliminaires sur le paludisme humain en zones rurale et sémi-urbaine du département du Nkam (Littoral-Cameroun),” Journal of Applied Biosciences, vol. 115, no. 1, pp. 11441–11452, 2017.
View at: Publisher Site | Google Scholar
Minsanté, Plan stratégique de lutte contre le paludisme au Cameroun, Ministère de la Santé Publique au Cameroun, 2018.
C. Antonio-Nkondjio, C. Ndo, F. Njiokou et al., “Review of malaria situation in Cameroon: technical viewpoint on challenges and prospects for disease elimination,” Parasite and Vectors, vol. 12, no. 1, p. 501, 2019.
View at: Publisher Site | Google Scholar
F. Benoit-Vical, L. Paloque, and J. M. Augereau, “Plasmodium falciparum resistance to artemisinin-based combination therapies (ACTs): fears of widespread drug resistance,” Bulletin de L'academie Nationale de Medecine, vol. 200, no. 3, pp. 477–490, 2016.
View at: Publisher Site | Google Scholar
A. Carillon, “Place de la phytothérapie dans les systèmes de santé au XXI s,” SIPAM, pp. 1–7, 2009.
View at: Google Scholar
N. Fatimata, Etude phytochimique et biologique de deux plantes médicinales de Côte d’Ivoire: Lantana camara et Lantana rhodesiensis (Verbenaceae), UNIVERSITÉ Felix Houphouet-Boigny. Département de Sciences Agronomiques et Ingénierie Biologique, 2021.
A. Maroyi, “Ethnopharmacology and therapeutic value of Bridelia micrantha (Hochst.) baill. In tropical Africa: a comprehensive review,” Molecules, vol. 22, no. 9, p. 1493, 2017.
View at: Publisher Site | Google Scholar
N. Nadia, J. Pone, N. Arlette et al., “In vitro antiplasmodial and antioxidant activities of Entandrophragma cylindricum (Meliaceae) extracts,” European Journal of Medicinal Plants, vol. 21, no. 1, pp. 1–9, 2017.
View at: Publisher Site | Google Scholar
I. Ciulei, Practical manuals on the industrial utilization of chemical and aromatic plants. Methodology for analysis of vegetable drugs, Ministry of Chemical Industry, Bucarest, 1982.
W. Trager and J. B. Jensen, “Human malaria parasites in continuous culture,” Science, vol. 193, no. 4254, pp. 673–675, 1976.
View at: Publisher Site | Google Scholar
C. Lambros and J. P. Vanderberg, “Synchronization of Plasmodium falciparum erythrocytic stages in culture,” The Journal of Parasitology, vol. 65, no. 3, p. 418, 1979.
View at: Publisher Site | Google Scholar
M. Smilkstein, N. Sriwilaijaroen, J. X. Kelly, P. Wilairat, and M. Riscoe, “Simple and inexpensive fluorescence-based technique for high-throughput antimalarial drug screening,” Antimicrobial Agents and Chemotherapy, vol. 48, no. 5, pp. 1803–1806, 2004.
View at: Publisher Site | Google Scholar
C. Popovici, I. Saykova, and B. Tylkowski, “Evaluation de l'activité antioxydant des composés phénoliques par la réactivité avec le radical libre DPPH,” Revue de Génie Industriel, vol. 4, pp. 25–39, 2009.
View at: Google Scholar
J. Bokhari, R. K. Muhammad, S. Maria, R. Umbreen, J. Shumaila, and A. Z. Jawaid, “Evaluation of diverse antioxidant activities of _Galium aparine_,” Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, vol. 102, pp. 24–29, 2013.
View at: Publisher Site | Google Scholar
D. Ashokkumar, V. Thamilselvan, U. K. Mazumder, and M. Gupta, “Antioxidant and free radical scavenging effects ofLippia nodiflora,” Pharmaceutical Biology, vol. 46, no. 10-11, pp. 762–771, 2008.
View at: Publisher Site | Google Scholar
R. J. Ruch, K. A. Crist, and J. E. Klaunig, “Effects of culture duration on hydrogen peroxide-induced hepatocyte toxicity,” Toxicology and Applied Pharmacology, vol. 100, no. 3, pp. 451–464, 1989.
View at: Publisher Site | Google Scholar
S. Sinha, D. I. Batovska, B. Medhi et al., “In vitro anti-malarial efficacy of chalcones: cytotoxicity profile, mechanism of action and their effect on erythrocytes,” Malaria Journal, vol. 18, no. 1, p. 421, 2019.
View at: Publisher Site | Google Scholar
T. Bowling, L. Mercer, R. Don, R. Jacobs, and B. Nare, “Application of a resazurin-based high-throughput screening assay for the identification and progression of new treatments for human African trypanosomiasis,” International Journal for Parasitology: Drugs and Drug Resistance, vol. 2, pp. 262–270, 2012.
View at: Publisher Site | Google Scholar
S. Kumari, P. Satish, K. Somaiah, S. Rekha, P. Brahmam, and K. Sunita, “Antimalarial activity of Polyalthia longifolia (false ashoka) against chloroquine sensitive Plasmodium falciparum 3D7 strain,” World Journal of Pharmaceutical Sciences, vol. 4, no. 6, pp. 495–501, 2016.
View at: Google Scholar
A. Edith, A. Joseph, A. Oyindamola et al., “Antimalarial ethnobotany: in vitro antiplasmodial activity of seven plants identified in the Nigerian Middle Belt,” Pharmaceutical Biology, vol. 42, no. 8, pp. 588–591, 2004.
View at: Publisher Site | Google Scholar
R. S. Nondo, D. Zofou, M. J. Moshi et al., “Ethnobotanical survey and in vitro antiplasmodial activity of medicinal plants used to treat malaria in Kagera and Lindi regions, Tanzania,” Journal of Medicinal Plants Research, vol. 9, no. 6, pp. 179–192, 2015.
View at: Google Scholar
J. C. Tomani, O. Bonnet, A. Nyirimigabo et al., “In vitro antiplasmodial and cytotoxic activities of compounds from the roots of Eriosema montanum Baker f. (Fabaceae),” Molecules, vol. 26, no. 9, p. 2795, 2021.
View at: Publisher Site | Google Scholar
K. Esseh, Y. G. Afanyibo, K. Y. Ahama-Esseh et al., “Screening Phytochimique, Étude Toxicologique, Évaluation des Activités Antiplasmodiale et Antiradicalaire de la Tige Feuillée de Senna occidentalis Linn (Fabaceae),” European Scientific Journal, vol. 15, no. 6, p. 411, 2019.
View at: Publisher Site | Google Scholar
P. Chaudhary and P. Janmeda, “Quantification of phytochemicals and in vitro antioxidant activities from various parts of Euphorbia neriifolia Linn,” Journal of Applied Biology and Biotechnology, vol. 10, no. 2, pp. 133–145, 2022.
View at: Google Scholar
B. Halliwell and M. Whiteman, “Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean?” British Journal of Pharmacology, vol. 142, no. 2, pp. 231–255, 2004.
View at: Publisher Site | Google Scholar
J. Zhou, P. Wu, F. Wang, and J. Chen, “Targeting gaseous molecules to protect against cerebral ischaemic injury: mechanisms and prospects,” Clinical and Experimental Pharmacology and Physiology, vol. 39, no. 6, pp. 566–576, 2012.
View at: Publisher Site | Google Scholar
G. C. Jagetia and T. K. Reddy, “Alleviation of iron induced oxidative stress by the grape fruit flavanone naringin in vitro,” Chemico-biological interactions, vol. 190, no. 2-3, pp. 121–128, 2011.
View at: Publisher Site | Google Scholar
M. Viuda-Martos, Y. Ruiz-Navajas, J. Fernández-López, E. Sendra, E. SayasBarberá, and J. A. Pérez-Álvarez, “Antioxidant properties of pomegranate (_Punica granatum_ L.) bagasses obtained as co-product in the juice extraction,” Food Research International, vol. 44, no. 5, pp. 1217–1223, 2011.
View at: Publisher Site | Google Scholar
H. M. Malebo, W. Tanja, M. Cal et al., “Antiplasmodial, antitrypanosomal, anti-leishmanial and cytotoxicity activity of selected Tanzanian medicinal plants,” Tanzania Journal of Heath Research, vol. 11, pp. 226–234, 2009.
View at: Publisher Site | Google Scholar
J. Bapela, H. Heyman, F. Senejoux, and M. Meyer, “¹H NMR-based metabolomics of antimalarial plant species traditionally used by Vha-Venda people in Limpopo Province, South Africa and isolation of antiplasmodial compounds,” Journal of Ethnopharmacology, vol. 228, pp. 148–155, 2019.
View at: Publisher Site | Google Scholar
L. Costa-Lotufo, M. Khan, A. Ather et al., “Studies of the anticancer potential of plants used in Bangladeshi folk medicine,” Journal of Ethnopharmacology, vol. 99, no. 1, pp. 21–30, 2005.
View at: Publisher Site | Google Scholar

Copyright

Copyright © 2023 Tako Djimefo Alex Kevin et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PDF Download Citation

Download other formats

Order printed copies

Views

421

Downloads

381

Citations